This was a sub-study based upon banked blood of the REVERSALtrial.
这是一个源于REVERSAL试验库存血的分支研究。
2
Dr Ira Pastor, the CEO of Bioquark Inc. said: "This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime."